Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
Background: In recent years, several clinical trials have focused on oncolytic virus (OVs) combined with chemotherapy or immune checkpoint inhibitors (ICIs) in solid tumor patients, which showed encouraging effects. However, few studies have concentrated on the summary on the safety and efficacy of...
Saved in:
Main Authors: | Xiangxing Liu (Author), Jiaojiao Zhang (Author), Keqing Feng (Author), Simin Wang (Author), Liming Chen (Author), Suping Niu (Author), Qian Lu (Author), Yi Fang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing oncolytic virus-mediated immunity
by: Volker Schirrmacher
Published: (2015) -
Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria
by: Jason M. Roe, et al.
Published: (2023) -
Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy
by: Shike Lou, et al.
Published: (2024) -
Oncolytic Virus Immunotherapy
Published: (2022) -
Safety of COVID-19 vaccines in subjects with solid tumor cancers receiving immune checkpoint inhibitors
by: Danielle Gilbert, et al.
Published: (2023)